Literature DB >> 22201740

Angiotensin II induces inflammation leading to cardiac remodeling.

Lixin Jia1, Yulin Li, Chuanshi Xiao, Jie Du.   

Abstract

Hypertension, especially for elevated renin-angiotensin II (Ang II), induces cardiac fibrosis and remodeling. Ang II, acting via its receptors, causes both hemodynamic and nonhemodynamic effects. These effects trigger a series of inflammatory responses. Recent studies have demonstrated that hypertension stimulates infiltration of leukocytes into heart, and interaction among macrophages, T cells, and monocytic fibroblast precursor cells regulates the imbalance of pro-inflammatory and anti-inflammatory factors. Several studies have demonstrated that the inflammatory microenvironment in hypertensive heart promotes a forward feedback infiltration of leukocytes, differentiation of monocytes, and formation of myofibroblasts. An increased number of myofibroblasts, the dominant source of extracellular matrix production, results in deposition of collagen and cardiac remodeling. A thorough understanding of the pathological process underlying hypertension-induced cardiac remodeling may help in prevention and treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22201740     DOI: 10.2741/3923

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  32 in total

1.  Identification and characterization of a highly thermostable bacteriophage lysozyme.

Authors:  R Lavigne; Y Briers; K Hertveldt; J Robben; G Volckaert
Journal:  Cell Mol Life Sci       Date:  2004-11       Impact factor: 9.261

2.  Mir-351-5p contributes to the establishment of a pro-inflammatory environment in the H9c2 cell line by repressing PTEN expression.

Authors:  Walmir da Silva; Robson Augusto Souza dos Santos; Karen C M Moraes
Journal:  Mol Cell Biochem       Date:  2015-11-05       Impact factor: 3.396

3.  Mitochondrial coupling factor 6 upregulation in hypertension-induced cardiac hypertrophy.

Authors:  Tao He; Aili Guan; Yue Shi; Zhiming Ge; Hongyan Dai
Journal:  Herz       Date:  2015-04-22       Impact factor: 1.443

4.  CYP epoxygenase 2J2 prevents cardiac fibrosis by suppression of transmission of pro-inflammation from cardiomyocytes to macrophages.

Authors:  Lei Yang; Li Ni; Quanlu Duan; Xingxu Wang; Chen Chen; Song Chen; Sandip Chaugai; D C Zeldin; Jia Rong Tang; Dao Wen Wang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2015-02-14       Impact factor: 3.072

5.  The 3' Untranslated Region Protects the Heart from Angiotensin II-Induced Cardiac Dysfunction via AGGF1 Expression.

Authors:  Lexi Ding; Shan Lu; Yu Zhou; Dayin Lyu; Changhan Ouyang; Zejun Ma; Qiulun Lu
Journal:  Mol Ther       Date:  2020-02-05       Impact factor: 11.454

6.  Modulation of angiotensin II-induced inflammatory cytokines by the Epac1-Rap1A-NHE3 pathway: implications in renal tubular pathobiology.

Authors:  Ping Xie; Darukeshwara Joladarashi; Pradeep Dudeja; Lin Sun; Yashpal S Kanwar
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-19

7.  Modulation of brain ACE and ACE2 may be a promising protective strategy against cerebral ischemia/reperfusion injury: an experimental trial in rats.

Authors:  Maha Mohammed Abdel-Fattah; Basim Anwar Shehata Messiha; Ahmed Mohamed Mansour
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-17       Impact factor: 3.000

8.  Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates angiotensin II-induced hypertensive heart disease in rats.

Authors:  P M Snijder; A R Frenay; R A de Boer; A Pasch; J L Hillebrands; H G D Leuvenink; H van Goor
Journal:  Br J Pharmacol       Date:  2015-03       Impact factor: 8.739

9.  Expression of Angiotensin II Type 1 Receptor in Rat Bladder Smooth Muscle Cells in Response to a Streptzotocin Induced Diabetes Mellitus Model.

Authors:  Shohei Tobu; Mitsuru Noguchi; Teppei Hatada; Ken-Ichi Mori; Manabu Matsuo; Hideki Sakai
Journal:  Curr Urol       Date:  2012-09-27

10.  Angiotensin II-Induced End-Organ Damage in Mice Is Attenuated by Human Exosomes and by an Exosomal Y RNA Fragment.

Authors:  Linda Cambier; Jorge F Giani; Weixin Liu; Takeshi Ijichi; Antonio K Echavez; Jackelyn Valle; Eduardo Marbán
Journal:  Hypertension       Date:  2018-06-04       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.